BIO-key(R) International, Inc. Joins Integrated Pa

WALL, NJ--(Marketwired - Oct 23, 2014) - BIO-key International, Inc. (OTCQB: BKYI), a leader in fingerprint biometric identification technologies, cloud-based mobile credentialing and identity verification solutions, today reported that the company will be presenting its biometric donor identification solutions at the AABB annual meeting, held at the Pennsylvania Convention Center, October 25^th - 28^th. BIO-key's technology is integrated with and being demonstrated by both Healthcare-ID, and Blood Bank Computer Systems; two leading providers of software platforms to the largest blood centers in the United States. 

To date, BIO-key has issued over 3 million TruDonor Identification licenses to blood centers that recognize the value and security of migrating away from traditional donor ID cards. Fingerprint identification has exploded in popularity with the introduction of the Touch ID ™ fingerprint authentication in Apple and Samsung phones. BIO-key's TruDonor platform delivers a fast positive identifier and eliminates the need to issue, replace or update donor identification cards, saving production and postage costs. By automating the donor check-in process, blood center staff can focus on making the donation experience a positive one that the donor will want to repeat. Centers that use BIO-key's TruDonor Identification benefit because their donor population always has an instant, dependable ID with them. At this year's event, BIO-key will also participate in a special four-industry partner demonstration which includes Applied-Sciences, Blood Bank Computer Systems and Digi-Trax. The four companies will be demonstrating an integrated blood and donor management ecosystem designed to offer optimum security, compliance and workflow performance. This multi-booth experience starts at BIO-key's booth, #217.

"Donor identification remains a very compelling opportunity because we make a difference in streamlining the gift of life process," said Jim Sullivan, Vice President of Strategy and Business Development, BIO-key. "When blood centers use TruDonor Identification, they speed the donor check-in, ensure a positive ID and prevent duplicate donor creation, without having to exhaustively scrub through the tea leaves in their donor data, looking for potential duplicates. There are simply too many vulnerabilities and negative outcomes from using donor ID cards. They can be shared, duplicated, manipulated, lost and stolen. Our partnerships with great companies in the blood bank software market are a great way to make this solution available without having to piece the parts together. We work together as one seamless solution," added Sullivan.

About BIO-key 

BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key's award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world's largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key's technology is offered directly or by market leading partners around the world. (http://www.bio-key.com)

BIO-key Safe Harbor Statement

Certain statements contained in this press release and in other public statements by the Company and Company officers include or may contain certain forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding our future financial position, business strategy and plans and objectives of management for future operations, are forward-looking statements. The words "anticipate," "believe," "estimate," "will," "may," "future," "plan," "intend" and "expect" and similar expressions generally identify forward-looking statements. These forward-looking statements are not guarantees and are subject to known and unknown risks, uncertainties and assumptions that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. Although we believe that our plans, intentions and expectations reflected in the forward-looking statements are reasonable, we cannot be sure that they will be achieved. Particular uncertainties that could cause our actual results to be materially different than those expressed in our forward-looking statements include: our history of losses and limited revenue; our ability to raise additional capital; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition between us and other companies in the biometric technology industry; market acceptance of biometric products generally and our products under development; delays in the development of products and statements of assumption underlying any of the foregoing, as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2013 filed with the Securities and Exchange Commission. All subsequent written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the foregoing. Except as required by law, we undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.